Skip to search formSkip to main contentSkip to account menu

FG 5803

Known as: 1-Piperazinecarboxamide, N-cyclohexyl-4-04-((4-fluorophenyl)-4-oxobutyl)-, monohydrochloride, FG-5803, FG5803 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Piperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
High frequency oral movements induced by long-term administration of amperozide but not FG5803 in rats
Long-term studies of antipsychotic-induced oral movements may serve as a rat model of acute and tardive movement disorders… 
Highly Cited
1995
Highly Cited
1995
D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs
The affinities of 13 atypical and 12 typical antipsychotic drugs for the cloned rat D4 dopamine receptor and the D4/D2 ratios… 
1994
1994
In the search for a novel class of antipsychotic drugs: preclinical pharmacology of FG5803, a 1-piperazinecarboxamide derivative.
Comparative studies of the 1-piperazinecarboxamide derivative 4-[3-(4-fluorobenzoyl)propyl]-N-cyclohexyl-1-piperazinecarboxamide… 
1992
1992
FG5803: POTENTIAL MECHANISMS OF ATYPICAL ANTIPSYCHOTIC ACTION
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)